Clinical Trial Detail

NCT ID NCT01880437
Title A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myleodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

Cytarabine + Vismodegib

Age Groups: adult

No variant requirements are available.